Winter 2020/2021 Vol. 10 Issue 04
-
From the Editor-in-Chief
Intercepting Cancer by Tackling PrecancerResearch on premalignancy is needed to fully tap the potential of cancer interception.
by William G. Nelson, MD, PhD
-
-
Your Cancer Guide
New Rules of EngagementAs the pandemic continues, cancer patients and survivors must weight fears of possible infection with their need to live fully.
by Hester Hill Schnipper
-
Caregiving With Confidence
Anticipatory GriefWhen a loved one has advanced cancer, it's common to mourn the loss that hasn't happened yet.
by Karen J. Bannan
-
Policy Matters
Cancer Scientists Support COVID-19 ResponseResearchers study ways to improve telehealth capabilities, clinical trials and health disparities.
by Trevan Locke, PhD
-
Are Liquid Biopsies Ready for the Clinic?Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.
by Kendall K. Morgan
-
Getting Serious About DepressionCancer survivors have higher rates of depression than the general population, but many don't know help is available.
by Cameron Walker
-
Multiple Myeloma: Choosing Your PathNew therapies provide hope and options for people as they monitor and manage this incurable blood cancer.
by Tara Haelle
-
Survivor Profile
A Voice at RiskRob Paulsen has voiced hundreds of animated characters, but as he prepared to return to a beloved role, cancer threatened his livelihood.
by Bradley Jones
-
-
Q&A
Ethics in PracticeRebecca Dresser explores the history and burdens of clinical trials through the lens of a cancer survivor and medical ethicist.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersExperts answer questions about limiting exposure to the coronavirus, how to talk about a cancer recurrence with loved ones, and strategies for dealing with a loss of health insurance.
-
Get Involved
Smiling FacesRich Nardiello seeks to bring a smile to children with cancer.
by Bradley Jones
-
Facts and Stats
2020: Cancer in the U.S.Data collected from cancer registries help chart the national burden of cancer.
by Bradley Jones
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
